09-13 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on September 18, 2026 CI
06-11 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on June 18, 2026 CI
06-04 IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2026 CI
03-15 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on March 20, 2026 CI
12-14 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on December 19, 2025 CI
25-09-14 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on September 19, 2025 CI
25-03-16 IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on March 21, 2025 CI
24-12-03 IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2024 CI
24-06-04 IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2024 CI
23-12-01 IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2023 CI
23-06-01 IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2023 CI
21-06-04 IShares Trust - iShares Nasdaq Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2021 CI
20-06-04 Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-1.60% - - 11.14B
Average +0.31%
Weighted average by Cap. +0.31%
Logo iShares Trust - iShares Nasdaq Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.
Employees
-